National Comprehensive Cancer Network



About NCCN

Acute Lymphoblastic Leukemia Panel - Disclosures as of 3/2/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Joseph C. Alvarnas, MD

National Cancer Institute;
Clinical Trials Network

None

Plexus Communications

None

None

12/15/2014

Patricia Aoun, MD, MPH

None

None

None

None

None

8/26/2014

Karen Kuhn Ballen, MD

None

None

None

None

None

10/16/2014

Stefan K. Barta, MD, MS, MRCP

Millennium Pharmaceuticals, Inc.;
Kyowa Hakko Kirin;
Optimer;
Otsuka Pharmaceuticals;
Seattle Genetics

Onyx Pharmaceuticals, Inc.;
Seattle Genetics

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Seattle Genetics;
Pharmacyclics

None

None

9/24/2014

Marian Birkeland, PhD

None

None

None

None

None

10/7/2014

Uma Borate, MD

Eli Lilly and Company;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Seattle Genetics;
Pfizer Inc.

Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.

None

None

1/29/2015

Michael W. Boyer, MD

None

None

None

None

None

1/29/2015

Patrick A. Brown, MD

None

None

None

None

None

12/18/2014

Patrick Burke, MD

None

None

None

None

None

10/18/2014

Ryan Cassaday, MD

Seattle Genetics;
Pfizer Inc.

None

None

None

None

1/29/2015

Januario E. Castro, MD

         

Pending

Peter F. Coccia, MD

None

None

None

None

None

12/10/2014

Steven E. Coutre, MD

Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
AbbVie;
Gilead;
Pharmacyclics

Celgene Corporation

Celgene Corporation;
Novartis Pharmaceuticals Corporation;
AbbVie;
Gilead;
Pharmacyclics

None

None

9/16/2014

Lloyd E. Damon, MD

Sigma-Tau Pharmaceuticals, Inc.;
Sunesis Pharmaceuticals, Inc.

None

None

None

None

12/14/2014

Daniel J. DeAngelo, MD, PhD

None

Amgen Inc.;
ARIAD Pharmaceuticals, Inc.;
AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Incyte;
Pfizer Inc.;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

1/27/2015

Dan Douer, MD

Amgen Inc.;
Bristol-Myers Squibb Company;
Sigma-Tau Pharmaceuticals, Inc.

Gilead;
Spectrum;
Sigma-Tau Pharmaceuticals, Inc.

Jazz Pharmaceuticals

None

None

12/3/2014

Fayna Ferkle, PharmD

None

None

None

None

None

10/14/2014

Olga Frankfurt, MD

None

None

None

None

None

1/8/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

John P. Greer, MD

None

None

None

None

None

9/10/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

9/16/2014

Robert A. Johnson, MD, FACP

None

None

None

None

None

1/23/2015

Rebecca B. Klisovic, MD

Novartis Pharmaceuticals Corporation

Gilead;
Spectrum Pharmaceuticals

None

None

None

2/16/2015

Gary Kupfer, MD

None

lawyer

None

None

None

9/23/2014

Mark Litzow, MD

Amgen Inc.;
Spectrum Pharmaceuticals;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

None

9/20/2014

Arthur Liu, MD

None

None

None

None

None

10/16/2014

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

10/1/2014

Arati V. Rao, MD

None

Amgen Inc.;
Boehringer Ingelheim GmbH

None

None

None

1/23/2015

Bijal Shah, MD

Celgene Corporation;
Acetylon;
Seattle Genetics

Bayer HealthCare;
Celgene Corporation;
Acetylon

Celgene Corporation;
Jannsen Pharmaceutica Products, LP

None

None

1/28/2015

Courtney Smith, PhD

None

None

None

Johnson & Johnson;
OPKO

Ethos Health Communications

11/7/2014

Geoffrey Uy, MD

Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
sanofi-aventis U.S.

Boehringer Ingelheim GmbH

None

None

None

12/12/2014

Andrew D. Zelenetz, MD, PhD

Abbott Laboratories;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Constellation Pharmaceuticals;
Curis;
Gilead;
Infinity;
Seattle Genetics

Amgen Inc.;
Celgene Corporation;
Genentech, Inc.;
Adaptive Biotechnology;
Alissa Pharma;
Gilead;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None

1/26/2015